Number of participants experiencing muscle‐related adverse events: e.g. soreness, discomfort, cramps, pain · men with urinary incontinence following prostate surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of participants experiencing muscle‐related adverse events: e.g. soreness, discomfort, cramps, pain · men with urinary incontinence following prostate surgery
It is very uncertain whether combinations of conservative treatments changes number of participants experiencing muscle‐related adverse events:… compared with no treatment, sham treatment or verbal/written instruction (very low certainty).
1 finding from 1 review
Number of participants experiencing muscle‐related adverse events: e.g. soreness, discomfort, cramps, pain · men with urinary incontinence following prostate surgery
1 finding from 1 review
Adverse events: all ‐ other events ‐ not listed above (e.g. dysuria, neck pain, eye discomfort) (secondary outcome) · people with depression after stroke
It is very uncertain whether pharmacological intervention and non‐invasive brain stimulation… changes adverse events: all ‐ other events ‐ not listed above (e.g.… compared with a pharmacological intervention and sham stimulation or usual care… (very low certainty).
1 finding from 1 review
Adverse events: all ‐ other events ‐ not listed above (e.g. dysuria, neck pain, eye discomfort) (secondary outcome) · people with depression after stroke
Non‐invasive brain stimulation showed no clear difference in adverse events: all ‐ other events ‐ not listed above (e.g. dysuria,… compared with sham non‐invasive brain stimulation and/or usual care (low certainty).
1 finding from 1 review
Adverse events (hospital records/every 6 weeks) · asymptomatic carotid stenosis
Lipid‐lowering agent showed no clear difference in adverse events (only reported for two studies: one study used CT… compared with placebo or no treatment (low certainty).
1 finding from 1 review
Direct adverse events (reoperation): we report reoperation for removal of implant as this is the most clinically relevant. Other adverse events with data included: loss of fixation, superficial infection, deep infection, haematoma formation, impla... · adults with fractures of the distal femur
It is very uncertain whether retrograde intramedullary nail (RIMN) changes direct adverse events (reoperation): we report reoperation for… compared with locking plate (very low certainty).
1 finding from 1 review
Intervention not reported
Any adverse events · informal caregivers of people affected by cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Major adverse events · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether surgical thrombectomy changes major adverse events compared with different types of endovascular interventions (very low certainty).
1 finding from 1 review
Minor adverse events · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether surgical thrombectomy changes minor adverse events compared with different types of endovascular interventions (very low certainty).
1 finding from 1 review
Number withdrawn due to adverse events · patients for whom migraine preventive interventions are indicated
It is very uncertain whether SSRIs or SNRIs changes withdrawn (due to adverse events) compared with placebo (very low certainty).
1 finding from 1 review
Severe adverse events · adults with renal vasculitis for maintenance therapy
Azathioprine may leads to lower severe adverse events compared with methotrexate (low certainty).
1 finding from 1 review
Serious adverse events · adults with olfactory dysfunction for ≥ 4 weeks following COVID‐19 infection
1 finding from 1 review
Serious adverse events · adults with olfactory dysfunction for ≥ 4 weeks following COVID‐19 infection
1 finding from 1 review
Serious adverse events · people with olfactory dysfunction for less than 4 weeks following COVID‐19 infection
1 finding from 1 review
Serious adverse events · adults with renal vasculitis for maintenance therapy
Azathioprine showed no clear difference in serious adverse events compared with cyclophosphamide (moderate certainty).
1 finding from 1 review
Serious adverse events · IBD patients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Serious adverse events for all placebos · patients with mental health disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events* · adults with renal vasculitis for maintenance therapy
Leflunomide showed no clear difference in serious adverse events* compared with methotrexate (low certainty).
1 finding from 1 review
Primary outcome 3: Adverse events · people (all patch‐tested) with hand eczema > 6 months that had cleared upon daily treatment for a maximum of 9 weeks with mometasone…
Corticosteroid creams/ointments: mometasone furoate cream 3 times/week showed no clear difference in primary: adverse events compared with 2 times/week (low certainty).
1 finding from 1 review